DMAC - Company ID 0001401040
The table below shows DiaMedica Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.13M | $4.87M | $3.33M | $4.11M | $2.59M | $4.13M |
| Short-term investments | $38.38M | $46.46M | $51.99M | $25.93M | $33.73M | $46.06M |
| Receivables | $244.00K | $301.00K | $260.00K | $161.00K | $253.00K | $290.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $44.31M |
| $52.36M |
| $56.22M |
| $31.08M |
| $37.42M |
| $50.77M |
| Property, plant & equipment | $133.00K | $142.00K | $150.00K | $152.00K | $149.00K | $151.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $45.00M | $53.08M | $57.05M | $31.47M | $38.83M | $52.52M |
| Accounts payable | $2.81M | $3.29M | $1.92M | $1.26M | $1.51M | $1.17M |
| Total current liabilities | $6.59M | $5.75M | $5.27M | $4.12M | $4.67M | $4.30M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$192.95M | -$182.81M | -$164.03M | -$155.41M | -$147.71M | -$132.10M |
| Total equity | $38.34M | $47.23M | $51.62M | $27.17M | $33.95M | $47.96M |